Search Results - david+norris

1 Results

Sort By:

MCL1 Inhibitor Combination Therapy for the Treatment of Melanoma

Melanoma causes the majority of skin cancer related deaths in the US despite only accounting for 1% of skin cancer cases. Immunotherapy has improved survival for melanoma patients, however 50% of these individuals will be refractory to first line treatment. Dr. Shellman and her team at the University of Colorado have identified a MCL1 inhibitor-immunotherapy...

Published: 5/22/2023 | Inventor(s): Yiqun Shellman, Richard Tobin, David Norris

Disease Areas Dermatology, Oncology

Category(s): Therapeutics